Tag Archive for: BII

From $1bn deals to Smart RNA – read our news roundup

AstraZeneca buys Novo Holdings portfolio company Amolyt in potential $1bn+ deal Novo Holdings A/S and Sofinnova Partners, two leading life sciences investors, made headlines on Thursday when portfolio company Amolyt Pharma entered into a definitive agreement to be acquired by AstraZeneca at a purchase price of US$800 million upfront and a potential milestone payment of […]

BII welcomes innovative smartRNA project to Bio Studio program

BioInnovation Institute (BII), an international non-profit foundation, incubating and accelerating world-class life science research, today announces that it has accepted a new project into its Bio Studio program to develop a small RNA-based platform technology for treating monogenic diseases caused by reduced protein levels, primarily haploinsufficiency disorders, which constitute a significant unmet medical need. The […]

Optimum’s clients build momentum in March

Optimum’s clients continued to gain momentum in March, starting things off on Monday with a substantial financing agreement for Heidelberg Pharma, with HealthCare Royalty for up to $115 million. On Wednesday, Heidelberg followed this with the announcement that it is to present first efficacy data from a Phase 1 clinical trial with ATAC candidate HDP-101. […]

BII welcomes twelve new companies to its Venture Lab program

BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today announces that twelve new companies have entered its Venture Lab acceleration program for early-stage companies. The cohort is strategically aligned with BII’s focus on supporting innovative early-stage start-ups that can improve human and planetary health. Read more…

The first six companies enter the Deep Tech Lab – Quantum start-up accelerator at BII to unlock the potential in quantum science

BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, announces the first cohort of companies to enter the new accelerator start-up program at  Deep Tech Lab – Quantum, to propel emergent and disruptive quantum science solutions. The Deep Tech Lab – Quantum is an independent accelerator operated by BII. Six […]